|
|
|
|
LEADER |
02710cam a2200349 u 4500 |
001 |
10090048 |
003 |
upatras |
005 |
20210117202803.0 |
008 |
110701s2003 eng |
020 |
|
|
|a 0471482706
|q ((electronic bk.))
|
020 |
|
|
|a 9780471482703
|q (electronic bk.) ((cloth : alk. paper))
|
020 |
|
|
|a 0471020117
|
020 |
|
|
|a 9780471020110
|q (cloth : alk. paper)
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
050 |
|
4 |
|a RB113
|b .S525 2003
|
082 |
1 |
4 |
|a 616.07
|2 21
|
245 |
1 |
0 |
|a Signal transduction and human disease
|h [electronic resource]
|c edited by Toren Finkel, J. Silvio Gutkind
|
260 |
|
|
|a Hoboken, NJ
|b Wiley-Interscience
|c c2003
|
300 |
|
|
|a xviii, 470 σ.
|b εικ.
|c 26 εκ
|
504 |
|
|
|a Περιέχει βιβλιογραφικές παραπομπές και ευρετήριο
|
505 |
1 |
|
|a Atherosclerosis: signal transduction by oxygen and nitrogen / Jonathan M. Hill, Ilsa L. Rovira, and Toren Finkel -- NF-kB: a key signaling pathway in asthma / Stewart J. Levine -- Molecular mechanisms of cancer / Akrit Sodhi, Silvia Montaner, and J. Silvio Gutkind -- Apoptotic pathways in cancer progression and treatment / Joya Chandra and Scott H. Kaufmann -- Molecular and cellular aspects of insulin resistance: implications for diabetes / Derek Le Roith, Michael J. Quon, and Yehiel Zick -- Dysfunction of G protein-regulated pathways and endocrine diseases / William F. Simonds -- Bacterial regulation of the cytoskeleton / Jeremy W. Peck, Dora C. Stylianou, and Peter D. Burbelo -- Bacterial toxins and diarrhea / Walter A. Patton, Joel Moss, and Martha Vaughan -- Molecular basis of severe combined immunodeficiency: lessons from cytokine signaling pathways / Roberta Visconti, Fabio Candotti, and John J. O'Shea -- Mast cell-related diseases: genetics, signaling pathways, and novel therapies / Michael A. Beaven and Thomas R. Hundley -- Rheumatology and signal transduction / Keith M. Hull and Daniel l. Kastner -- Molecular mechanisms of neurodegenerative disorders / Benjamin Wolozin -- Neurotropic signaling in mood disorders / Jing Du, Todd D. Gould, and Husseini K. Manji -- Inhibiting signaling pathways through rational drug design / James N. Topper and Neill A. Giese
|
650 |
|
4 |
|a Παθολογία
|9 5202
|
650 |
|
4 |
|a Ασθένειες
|9 63674
|
700 |
1 |
|
|a Finkel, Toren
|9 93270
|
700 |
1 |
|
|a Gutkind, J. Silvio
|9 93271
|
710 |
2 |
|
|a John Wiley & Sons
|9 48677
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|h 616.07 SIG
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/0471482706
|
942 |
|
|
|2 ddc
|
952 |
|
|
|0 0
|1 0
|4 0
|6 616_070000000000000_SIG
|7 0
|9 97871
|a LISP
|b LISP
|d 2016-04-24
|l 0
|o 616.07 SIG
|r 2016-04-24 00:00:00
|w 2016-04-24
|y ERS
|x Wiley E-Books
|
999 |
|
|
|c 65751
|d 65751
|